RenovoRx RNXT
NASDAQ RNXT
$1.55 -0.01 (-0.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Gross Margin (2025 - 2026)

Updated

RenovoRx (RNXT) reported Gross Margin of 84.27% for Q2 2026, up 20.29 percentage points from 63.98% a year earlier but down 0.81 percentage points from the prior quarter.

Analysis

RenovoRx (RNXT) Gross Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, RenovoRx's Gross Margin came in at 84.41%; for FY2025, it came in at 70.88%, down 29.12 percentage points from FY2024.

  • By year, Gross Margin came in at 100.00% in FY2024.
  • Five-year quarterly Gross Margin spans a low of 52.28% in Q1 2025 and a high of 88.24% in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 85.08% (Q1 2026), 88.24% (Q4 2025) and 80.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 40.70%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 57.71%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 57.64%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 67.78%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 64.99%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 68.27%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 70.71%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 77.46%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 46.46%
10 RenovoRx 70.39 Mn 70.39 Mn 766,000.00 84.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.27%
Mar 31, 2026 85.08%
Dec 31, 2025 88.24%
Sep 30, 2025 80.08%
Jun 30, 2025 63.98%
Mar 31, 2025 52.28%
API Access

RenovoRx Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=RNXT&period=max&api_key=YOUR_API_KEY